Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999814 · ClinicalTrials.gov registry record
Natural History of Infantile Neuroaxonal Dystrophy
A clinical trial, sponsored by Biojiva.
- Completed
- Registry status
- 13
- Enrollment target
NCT03999814: Completed study, sponsored by Biojiva.
NCT03999814 is a clinical trial that has completed, run by Biojiva. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03999814 has completed, sponsored by Biojiva.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This is a retrospective and cross-sectional review of the natural history of INAD.
Primary Outcome
Overall analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2020-02-27 |
What the finished NCT03999814 record still lists
NCT03999814 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03999814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03999814 about?
NCT03999814 is a clinical study titled "Natural History of Infantile Neuroaxonal Dystrophy". This is a retrospective and cross-sectional review of the natural history of INAD.
What is the current status of trial NCT03999814?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2018-07-30. Estimated completion is 2020-02-27.
Who is sponsoring clinical trial NCT03999814?
This trial is sponsored by Biojiva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI